Down -29.72% in 4 Weeks, Here's Why Surrozen (SRZN) Looks Ripe for a Turnaround
Zacks·4mo ago
More News
Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
In a preclinical model of pulmonary fibrosis, a Surrozen antibody-based SWAP platform molecule decreased pulmonary inflammation and fibrosis and improved lung function Surrozen Wnt mimetic SWAP...
Globe Newswire·1y ago
Surrozen announces up to $192.5M private placement of securities priced at-the-market under Nasdaq rules
Surrozen announces up to $192.5M private placement of securities priced at-the-market under Nasdaq rules...
Seeking Alpha - Healthcare·1y ago
Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
- $17.5 million upfront proceeds with up to an additional $175 million of proceeds upon the exercise of warrants- Initial capital funds expansion of Phase 1b trial in severe alcohol-associated...
Globe Newswire·1y ago
Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
-Phase 1a trial demonstrated acceptable safety and tolerability with no reported serious adverse events-Phase 1a data demonstrated target engagement, a pharmacodynamic effect and effects on liver...
Globe Newswire·1y ago
Surrozen announces safety, pharmacodynamic, liver function data for SZN-043
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
Surrozen announces up to $192.5M private placement
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
Surrozen, Inc. (NASDAQ:SRZN) Short Interest Update
Surrozen, Inc. (NASDAQ:SRZN - Get Free Report) was the recipient of a large growth in short interest in March. As of March 15th, there was short interest totalling 3,400 shares, a growth of 25.9...
Ticker Report·1y ago
Surrozen Provides Corporate Update on Clinical Programs
Announces strategic prioritization of clinical programs to focus on development of SZN-043 for Alcohol-Associated Hepatitis SZN-043- Completed enrollment for the Phase 1a clinical trial in chronic...